119 related articles for article (PubMed ID: 8382349)
1. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.
Berger AR; Arezzo JC; Schaumburg HH; Skowron G; Merigan T; Bozzette S; Richman D; Soo W
Neurology; 1993 Feb; 43(2):358-62. PubMed ID: 8382349
[TBL] [Abstract][Full Text] [Related]
2. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
Dubinsky RM; Yarchoan R; Dalakas M; Broder S
Muscle Nerve; 1989 Oct; 12(10):856-60. PubMed ID: 2558314
[TBL] [Abstract][Full Text] [Related]
3. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors.
Blum AS; Dal Pan GJ; Feinberg J; Raines C; Mayjo K; Cornblath DR; McArthur JC
Neurology; 1996 Apr; 46(4):999-1003. PubMed ID: 8780079
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
Anderson TD; Davidovich A; Arceo R; Brosnan C; Arezzo J; Schaumburg H
Lab Invest; 1992 Jan; 66(1):63-74. PubMed ID: 1309930
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
Dalakas MC; Semino-Mora C; Leon-Monzon M
Lab Invest; 2001 Nov; 81(11):1537-44. PubMed ID: 11706061
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine.
LeLacheur SF; Simon GL
J Acquir Immune Defic Syndr (1988); 1991; 4(5):538-9. PubMed ID: 1849990
[TBL] [Abstract][Full Text] [Related]
7. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
Chen X; Levine JD
Mol Pain; 2007 Feb; 3():5. PubMed ID: 17319957
[TBL] [Abstract][Full Text] [Related]
8. Dideoxycytidine: current clinical experience and future prospects. A summary.
Broder S; Yarchoan R
Am J Med; 1990 May; 88(5B):31S-33S. PubMed ID: 2159708
[TBL] [Abstract][Full Text] [Related]
9. Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
Ferrari LF; Levine JD
Eur J Neurosci; 2010 Sep; 32(5):811-8. PubMed ID: 20726883
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
Simpson DM; Tagliati M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):153-61. PubMed ID: 7749792
[TBL] [Abstract][Full Text] [Related]
11. Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Sanna MD; Peroni D; Quattrone A; Ghelardini C; Galeotti N
Exp Neurol; 2015 May; 267():53-63. PubMed ID: 25765490
[TBL] [Abstract][Full Text] [Related]
12. PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
Sanna MD; Quattrone A; Ghelardini C; Galeotti N
Pharmacol Res; 2014 Mar; 81():44-53. PubMed ID: 24565699
[TBL] [Abstract][Full Text] [Related]
13. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
Ruiz-Argüelles GJ; Lagunes-Yannelli B; Mercado-Díaz L
Rev Invest Clin; 1993; 45(2):145-7. PubMed ID: 8393211
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine.
Feldman D; Brosnan C; Anderson TD
Lab Invest; 1992 Jan; 66(1):75-85. PubMed ID: 1309931
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Sanna MD; Quattrone A; Mello T; Ghelardini C; Galeotti N
Exp Neurol; 2014 Nov; 261():343-53. PubMed ID: 24861443
[TBL] [Abstract][Full Text] [Related]
17. Theoretical mechanistic basis of the toxic effects and efficacy of dideoxycytidine in HIV:AIDS.
Akintonwa DA
Med Hypotheses; 2001 Aug; 57(2):249-51. PubMed ID: 11461183
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy: zalcitabine reassessed.
Carey P
Int J STD AIDS; 2000 Jul; 11(7):417-23. PubMed ID: 10919481
[TBL] [Abstract][Full Text] [Related]
19. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
[TBL] [Abstract][Full Text] [Related]
20. Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate.
Keilbaugh SA; Hobbs GA; Simpson MV
Mol Pharmacol; 1993 Oct; 44(4):702-6. PubMed ID: 8232219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
